记者丨骆轶琪 编辑丨朱益民 被称为"中国最贵耳机""耳机界爱马仕"的海菲曼，一家能实现超65%高毛利率的耳机品牌厂商，近日正 式在北交所IPO过会。 2024年，海菲曼毛利率一度飙升至70.1%，直追"奢侈品之王"爱马仕的70.3%。虽然AIoT品类整体毛利 率表现天然高于智能手机等硬件，但海菲曼呈现的水平依然远高于同业。 不过高盈利能力背后，成长挑战也隐隐浮现。21世纪经济报道记者梳理发现，近三年（2022-2024年） 公司研发占营业收入比重在5%上下浮动，但销售推广费用占营收比例却达到超过10%。而消费电子行 业本身有快速迭代属性，本质上对公司的研发和营销投流等能力有综合性考验。 除此之外，支撑海菲曼高毛利率表现的，是其营收构成中有超过一半比例来自海外市场，近些年来公司 也在完善对自建电商平台和国内销售渠道的能力延展，但综合来看，国内市场在耳机品类的消费能力整 体略逊于美、日这类发达消费市场。 而公司在答复交易所问询函中也提到，国内京东等渠道竞争相对激烈，对广告支出成本效益会带来一定 影响。 除了头戴式耳机这类发烧友级别高端市场，海菲曼近些年也在探路扩充产品矩阵，但目前来看，新品退 换货率有所攀升。 应 ...

Group 1 - The company operates in a capital-intensive industry with a continuous need for expansion, leading to high funding requirements, which also serves as a barrier to entry for competitors [2] - The company is in a phase of sustained growth, with rapid development in new businesses and fields necessitating ongoing investment in production capacity [2] - The company places significant emphasis on research and development (R&D) investments, consistently allocating a high proportion of funds to R&D expenses and equipment, with a long-term trend of increasing R&D spending [2]

Core Insights - The report titled "Great Power Competition: Future Global Technology Development Trends Forecast" predicts that by 2033, the top six countries in technological strength will be the United States, Israel, Germany, Japan, China, and Russia, based on 82 indicators such as R&D investment and patent numbers [3][5]. Group 1: Country Rankings and Strengths - The United States holds the top position, with a projected global innovation index ranking of third by 2025, leading in technology output, particularly in AI and quantum computing [8][10]. - Israel ranks second, with a high-tech industry that contributes significantly to its GDP, and an R&D expenditure of 6.35% of GDP, which is double the OECD average [12][13]. - Germany is ranked third, with a strong industrial base and a projected innovation index ranking of ninth by 2025, heavily investing in smart manufacturing and industrial 4.0 [15]. - Japan is in fourth place, with an innovation index ranking of twelfth by 2025, known for its meticulous attention to detail in technology and high R&D spending [16]. - China ranks fifth, showing rapid progress with a projected innovation index ranking of tenth by 2025, leading in patents and advancements in quantum computing and 5G technology [18]. - Russia is sixth, with a strong legacy in aerospace and nuclear energy, and a focus on advancing its scientific research capabilities [20]. Group 2: Future Outlook and Trends - The report anticipates that by 2025, the total number of patents among these six countries will increase by 15%, indicating a growing trend in international collaboration and project partnerships [22]. - By 2033, advancements in quantum networks and sustainable energy are expected to reshape the global technological landscape, benefiting the general public through improved technologies in mobile payments, healthcare, and green energy [24].

证券日报网讯 12月5日，万润科技在互动平台回答投资者提问时表示，公司以市场需求为导向，重视研 发投入，通过技术和产品创新、品牌及渠道建设、销售服务等方式，争取客户，扩大市场份额。 （文章来源：证券日报） ...

近日，临床前CRO企业百奥赛图正式登陆上交所科创板，引发市场关注。公司凭借"千鼠万抗"计划与 RenMice全人抗体平台，在生物医药领域具有一定技术积累与业务布局。然而，其招股书及财务数据背 后，却透露出盈利依赖研发压缩、关联交易占比高、专利侵权诉讼、未弥补亏损巨大等多重风险，值得 投资者警惕。 一、扭亏为盈背后的"成本压缩术"：研发投入大幅缩水 从财务表现看，百奥赛图在2022年至2024年间营业收入稳步增长，归母净利润从-6.02亿元转为正收益 3354.18万元，今年前三季度更是实现1.14亿元净利润，看似走出亏损泥潭。 然而，仔细观察发现，公司同期研发费用从6.99亿元骤降至3.24亿元，研发人员总数从627人减至337 人，专职研发人员更是从58人锐减至5人。2022至2024年间，公司营收增长4.46亿元，研发费用却下降 3.75亿元。这引发市场质疑：盈利改善是否更多来自"节流"而非真正的业务成长？公司解释称"大规模 研发阶段已结束"，但作为一家以技术为核心竞争力的生物医药企业，研发投入的持续性仍是其长期价 值的关键。 二、关联交易与专利诉讼双重隐患 抗体开发业务是百奥赛图的重要增长点，2022至 ...

Core Viewpoint - China Aluminum International (中铝国际) has successfully won a bid for a new electrolytic aluminum project in Shanxi, with a total contract value of 3.03 billion yuan, indicating strong growth in both domestic and international markets [1][3]. Group 1: Project Details - The project involves a total scale of 394,000 tons per year, with the first phase implementing 294,000 tons per year, utilizing an EPC (Engineering, Procurement, and Construction) contracting model [2][3]. - The consortium leading the bid includes Shenyang Aluminum Magnesium Design Research Institute, Shanghai Baoye Group, and other subsidiaries of China Aluminum International [2]. Group 2: Financial Performance - In the first three quarters of 2023, the company signed new contracts totaling 21.46 billion yuan, a year-on-year increase of 21.68% [3]. - The overseas market has seen explosive growth, with new foreign contracts amounting to 5.02 billion yuan, a significant increase of 115.91% compared to the same period last year [3]. - Domestic contracts reached 16.44 billion yuan, reflecting a steady growth of 7.37% year-on-year [3]. Group 3: Research and Development - China Aluminum International has consistently increased its R&D expenditure, with amounts of 760 million yuan, 912 million yuan, 943 million yuan, and 961 million yuan from 2021 to 2024, and 532 million yuan in the first three quarters of 2025, marking a year-on-year growth of 2.24% [5]. - Over the past five years, the total investment in R&D has reached approximately 4.108 billion yuan [5]. Group 4: Company Challenges and Adjustments - The company has experienced fluctuations in performance, with significant losses in 2020, 2021, and 2023, but managed to turn a profit in 2024 with a revenue of 24.003 billion yuan, a year-on-year increase of 7.46% [4]. - However, in the first three quarters of 2025, revenue declined by 5.72% to 15.219 billion yuan, and net profit dropped by 52.68% to 119 million yuan, attributed to reduced contributions from prior year's impairment reversals [4].

Core Insights - Amgen reported strong Q3 2025 earnings, with adjusted earnings of $5.64 per share, surpassing the Zacks Consensus Estimate of $5.00, and total revenues of $9.6 billion, exceeding the estimate of $8.9 billion, reflecting a 12% year-over-year increase [2][3] Financial Performance - Total product revenues increased by 12% year-over-year to $9.17 billion, driven by a 14% rise in volume, although partially offset by a 4% decline in pricing [3] - Other revenues rose by 19.3% year-over-year to $420 million, primarily due to higher royalty income [3] - Adjusted operating margin decreased by 2.5 percentage points to 47.1%, with operating expenses increasing by 18% to $5.25 billion [22] Key Product Performance - Prolia revenues reached $1.14 billion, up 9% year-over-year, significantly exceeding the Zacks Consensus Estimate of $911 million [6] - Evenity sales grew by 36% year-over-year to $541 million, surpassing the Zacks Consensus Estimate of $519 million [7] - Repatha generated revenues of $794 million, a 40% increase year-over-year, beating the Zacks Consensus Estimate of $720 million [7] - Biosimilar portfolio sales surged by 52% year-over-year to $775 million [5] Guidance and Outlook - Amgen raised its 2025 revenue and earnings outlook, expecting total revenues between $35.8 billion and $36.6 billion, and adjusted earnings per share in the range of $20.60 to $21.40 [24] - Adjusted operating margin is anticipated to be around 45%, with R&D expenses expected to grow at a mid-20s percentage rate year-over-year [25] Pipeline Developments - Enrollment has been completed in two phase III studies for MariTide, with approximately 5,000 adults enrolled [27] - Ongoing enrollment in two other phase III studies for atherosclerotic cardiovascular disease and heart failure [28]

近几年来，美的集团资本动作频频，相继收购控股了上市公司合康新能（300048）、万东医疗 （600055）和科陆电子（002121），分别介入了新能源与工业自动化、医疗影像和能源管理业务领域， 进一步强化了To B业务的新增长曲线。产经观察家丁少将评价称:"如果说美的集团的上半场是家电的故 事，那么下半场则会是B端的故事。" "十四五"时期，美的集团（000333）的华丽蜕变是广东资本市场发展的一个缩影。早年间，外界对美的 集团的印象还停留在家电层面。如今，美的集团已成功转型为一家覆盖智能家居、新能源与工业技术、 楼宇科技、机器人与自动化、健康医疗、智慧物流等业务于一身的多元化科技巨擘。 与并购扩张同步进行的是，美的集团在研发上的持续高强度投入。近五年来，美的集团累计研发投入超 过600亿元。美国商业专利数据库（IFI Claims）发布的"2023年全球250强专利领导者"榜单中，美的集 团专利家族数排名全球第八位、中国民营企业第一位。 目前，美的集团已在全球12个国家设立38个研发中心，构建起"2+4+N"的全球化研发网络。方洪波强 调，科技领先战略是美的集团的核心战略，美的集团将更加坚定地继续加大研发投 ...

当传统巨头收缩战线之际，比亚迪以"研发投入连续13年超净 利润"的长期主义，驱动销量跻身全球前五，诠释"技术为 王"的逆袭逻辑。 作者：薛致以 封图：图片资料室 近日，11月产销数据出炉。作为年末冲销量的晴雨表，11月销量是车企全年销量冲刺期的效果显 现，其中中国新能源汽车的月度成绩单再次成为焦点。龙头比亚迪11月单月新能源汽车销量达48 万辆，创下年内新高；此外上汽集团、吉利汽车的新能源汽车销量以及新势力品牌的销量均有不俗 的表现。 在全球汽车产业格局重塑的当下，中国新能源汽车正以前所未有的速度崛起，在全球市场渗透率不 断提升。在这股行业浪潮中，比亚迪的表现尤为突出，其不仅月度销量持续保持绝对领先优势，前 11个月累计销量更是达到418.2万辆，同比增长11.30%，继续保持行业榜首地位。 值得关注的是，在11月产销数据发布前夕，国内外车企相继发布三季度财报。不难发现，以比亚 迪为首的中国车企与全球巨头相比出现业绩分化现象，呈现出"东升西落"的态势。一边是外资巨 头增长乏力，甚至有车企出现利润腰斩，一边是中国车企普遍业绩向好，这不禁让人发问，为 何"比亚迪们"能够逆势保持平稳发展？ 具体来看，财报中一组差异 ...

Core Insights - The November sales data highlights the strong performance of China's electric vehicle (EV) industry, with BYD achieving a record monthly sales of 480,000 units, marking a year-high [1] - BYD's cumulative sales for the first eleven months reached 4.182 million units, reflecting a year-on-year growth of 11.3%, maintaining its leading position in the industry [1] - A divergence in performance is noted between Chinese automakers, led by BYD, and foreign giants, with the former showing robust growth while the latter struggles [1][4] Sales Performance - In November, BYD's sales reached 480,000 units, while other major players like SAIC and Geely also reported strong sales figures [1] - BYD's cumulative sales for the first eleven months of the year reached 4.182 million units, a year-on-year increase of 11.3% [1] R&D Investment - BYD's R&D expenditure for the first three quarters of the year was 43.7 billion yuan, a 31% increase year-on-year, positioning it as a leader in R&D investment among global automakers [1][4] - Over the past decade, BYD has invested over 220 billion yuan in R&D, consistently prioritizing technology as a core strategy [4] - In contrast, traditional foreign automakers like Volkswagen and BMW have reduced their R&D spending, indicating a more conservative approach to innovation [4] Technological Advancements - BYD has introduced innovative technologies such as the Tian Shen Eye driver assistance system and the Super e-platform, enhancing its product competitiveness [6] - The company ranks second globally in electric vehicle battery usage, with a total of 55.1 GWh in the third quarter, reflecting a year-on-year growth of 28.4% [6] Market Expansion - BYD's energy storage systems have positioned it among the top three globally, with significant projects like the largest energy storage project in Germany [7] - The company has seen a 136% year-on-year increase in overseas sales, reaching 700,000 units in the first three quarters, contributing significantly to its growth [11] Brand Development - BYD's high-end brand strategy has led to rapid increases in sales and market share, enhancing its global influence and technological authority [9] - The U9 Xtreme model has set a world record for electric vehicles, showcasing BYD's technological prowess and elevating the brand's status in the automotive industry [9]